Solid Dosage

Cardiovascular medication

GEA provides proven solutions for manufacturing even the most challenging dosage forms of cardiovascular medication.

Manufacturing Cardiovascular Medication

There are many types and combinations of medicines available to treat coronary heart disease (CHD), high blood pressure or heart failure, including anticoagulants, antiplatelet medications, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), beta blockers, calcium channel blockers, digoxin and diuretics.

Whatever the active ingredient, GEA provides proven solutions for even the most challenging dosage forms, such as MUPS tablets, effervescents and multi-layer dosage forms, as well as granules, pellets, modified/extended release formulations, powders designed for direct tableting or capsule filling and high-volume applications.

Still an important unit operation, coating is used to either add color, protect, mask the taste or create a modified release form in pharmaceutical production. GEA offers a range of standard, innovative, batch and continuous coater systems 

Plus, as containment experts, the company offers the largest selection of solutions for contained processing based on a thorough containment risk analysis.

Providing increased yields, lower utility consumption and reduced waste, continuous manufacturing presents a new approach to high-volume oral dosage form production and meets the industry’s demands for faster product development, reduced costs, improved production economics and increased manufacturing flexibility.

Downloads

GEA Insights

Human hands brought together to form a circle

Gesellschaftliches Engagement: Gemeinsam Gutes bewirken

Zur Unterstützung des gesellschaftlichen Engagements bietet GEA seinen Mitarbeitern einen Tag bezahlten Urlaub pro Jahr.

How a digital rotary parlor supports sustainable dairy farming

How do you lead a dairy farm into the next generation while ensuring a sustainable future and animal welfare while managing increasing complexity? This is a question almost every dairy farmer around the world must consider. The...

GEA misison 30 logo

Zukunft gestalten: GEA-CEO Stefan Klebert zur Mission 30

Nachdem GEA die Ziele der Mission 26 zwei Jahre früher erreicht hat, setzt sich das Unternehmen ambitionierte Ziele, um in den kommenden Jahren profitabel zu wachsen.

Erhalten Sie Nachrichten von GEA

Informieren Sie sich über GEA Innovationen und Erfolgsgeschichten, indem Sie die News von GEA abonnieren.

Haben Sie Fragen?

Wir helfen Ihnen gern weiter! Mit nur wenigen Angaben können wir Ihre Anfrage beantworten.

© GEA Group Aktiengesellschaft 2024

Cookie settings